ACVR1 Antibody (Center) Blocking peptide
€363.00
In stock
SKU
AC-BP13856c
Background:
Activins are dimeric growth and differentiation factorswhich belong to the transforming growth factor-beta (TGF-beta)superfamily of structurally related signaling proteins. Activinssignal through a heteromeric complex of receptor serine kinaseswhich include at least two type I ( I and IB) and two type II (IIand IIB) receptors. These receptors are all transmembrane proteins,composed of a ligand-binding extracellular domain withcysteine-rich region, a transmembrane domain, and a cytoplasmicdomain with predicted serine/threonine specificity. Type Ireceptors are essential for signaling; and type II receptors arerequired for binding ligands and for expression of type Ireceptors. Type I and II receptors form a stable complex afterligand binding, resulting in phosphorylation of type I receptors bytype II receptors. This gene encodes activin A type I receptorwhich signals a particular transcriptional response in concert withactivin type II receptors. Mutations in this gene are associatedwith fibrodysplasia ossificans progressive.
Other Names:
Activin receptor type-1, Activin receptor type I, ACTR-I, Activin receptor-like kinase 2, ALK-2, Serine/threonine-protein kinase receptor R1, SKR1, TGF-B superfamily receptor type I, TSR-I, ACVR1, ACVRLK2
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP13856c was selected from the Center region of ACVR1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: ACVR1
Gene ID: 90
Primary Accession: Q04771
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Activins are dimeric growth and differentiation factorswhich belong to the transforming growth factor-beta (TGF-beta)superfamily of structurally related signaling proteins. Activinssignal through a heteromeric complex of receptor serine kinaseswhich include at least two type I ( I and IB) and two type II (IIand IIB) receptors. These receptors are all transmembrane proteins,composed of a ligand-binding extracellular domain withcysteine-rich region, a transmembrane domain, and a cytoplasmicdomain with predicted serine/threonine specificity. Type Ireceptors are essential for signaling; and type II receptors arerequired for binding ligands and for expression of type Ireceptors. Type I and II receptors form a stable complex afterligand binding, resulting in phosphorylation of type I receptors bytype II receptors. This gene encodes activin A type I receptorwhich signals a particular transcriptional response in concert withactivin type II receptors. Mutations in this gene are associatedwith fibrodysplasia ossificans progressive.
Other Names:
Activin receptor type-1, Activin receptor type I, ACTR-I, Activin receptor-like kinase 2, ALK-2, Serine/threonine-protein kinase receptor R1, SKR1, TGF-B superfamily receptor type I, TSR-I, ACVR1, ACVRLK2
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP13856c was selected from the Center region of ACVR1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: ACVR1
Gene ID: 90
Primary Accession: Q04771
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review